Skip to main content
Caplight Logo









Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.

Private
HuzhouHealthcare & Life Scienceshttps://www.yaodou.cn/

Last Round

Debt

Jan 27, 2026

Total Funding Raised

$69.18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. is a pharmaceutical e-commerce and technology services company that operates the Yaodou platform, focusing on pharmaceutical distribution in the out-of-hospital segment in China.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Supply Chain, Retail Technology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

pharmaceutical distributionpharmaceutical e-commerceB2B procurementsupply chain managementpharma marketplaceout-of-hospital carechronic disease managementpharmacy franchisedigital pharmacyS2B2Ccross-border pharmae-healthhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Comparables

Compare Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmacist Bang
81%
111, Inc.
79%
Alibaba Group Holding Limited
75%

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 27, 2026
Series DMay 22, 2024
Series CApr 14, 2021
Series BJul 9, 2020
Series ASep 3, 2018

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Investors

Notable investors and investment history

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. investors
InvestorRounds
申万宏源证券资产管理有限公司Series B
Asian Development BankDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    $20M round led by Asian Development Bank.

  • Apr 14, 2021

    Raised $31M in Series C funding.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.

Is Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. a public or private company?

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. is a private company.

What is the current stock price of Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.?

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. worth (valuation)?

Valuation information for Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. is not publicly available.

Can I buy Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. stock?

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s last funding round?

Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s most recent funding round was Debt on January 27, 2026.

Who are the main investors in Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.?

Key investors in Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. include 申万宏源证券资产管理有限公司, Asian Development Bank.

Will Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd..

How can I track Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhejiang Xinghan Bona Pharmaceutical Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHuzhou
Year Founded2014
Last FundingJan 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?